Seth Klarman - Baupost Group
Holding/activity history for Enzon Pharmaceuticals Inc (EZ1)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2014 Q1 | 0 | 0.00 | Sell 100.00% | 0.18 | SEC | ||
| 2013 Q4 | 4,337,858 | 0.18 | Reduce 43.60% | 0.21 | $1.16 | $5,032,000 | SEC |
| 2013 Q3 | 7,691,453 | 0.48 | $1.68 | $12,922,000 | SEC | ||
| 2013 Q2 | 7,691,453 | 0.47 | $2.00 | $15,383,000 | SEC | ||
| 2013 Q1 | 7,691,453 | 1.09 | Reduce 2.02% | 0.03 | $3.80 | $29,228,000 | SEC |
| 2012 Q4 | 7,850,368 | 1.29 | Reduce 12.78% | 0.28 | $4.43 | $34,775,000 | SEC |
| 2012 Q3 | 9,000,878 | 2.19 | $6.96 | $62,646,000 | SEC | ||
| 2012 Q2 | 9,000,878 | 1.81 | $6.87 | $61,836,000 | SEC | ||
| 2012 Q1 | 9,000,878 | 2.38 | $6.84 | $61,566,000 | SEC | ||
| 2011 Q4 | 9,000,878 | 2.07 | $6.70 | $60,306,000 | SEC | ||
| 2011 Q3 | 9,000,878 | 2.38 | $7.04 | $63,366,000 | SEC | ||
| 2011 Q2 | 9,000,878 | 4.45 | $10.05 | $90,459,000 | SEC | ||
| 2011 Q1 | 9,000,878 | 7.26 | Reduce 0.71% | 0.06 | $10.90 | $98,110,000 | SEC |
| 2010 Q4 | 9,065,178 | 8.44 | Reduce 12.69% | 1.20 | $12.16 | $110,233,000 | SEC |
| 2010 Q3 | 10,382,698 | 9.44 | Add 2.03% | 0.19 | $11.24 | $116,727,000 | SEC |
| 2010 Q2 | 10,175,898 | 9.77 | Add 10.57% | 0.93 | $10.65 | $108,373,000 | SEC |
| 2010 Q1 | 9,203,100 | 7.07 | Add 13.87% | 0.86 | $10.18 | $93,688,000 | SEC |
| 2009 Q4 | 8,082,400 | 7.78 | Add 290.19% | 5.79 | $10.53 | $85,108,000 | SEC |
| 2009 Q3 | 2,071,382 | 1.81 | Buy | 1.81 | $8.25 | $17,089,000 | SEC |